Prokidney PROK
NASDAQ PROK
$1.63 +0.02 (+1.24%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prokidney (PROK) Revenue (2024 - 2026)

Updated

Prokidney's Revenue was $150,000 in Q2 2026, down 32.1% from $221,000 a year earlier and down 33.6% from the prior quarter.

Analysis

Prokidney (PROK) Revenue (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Prokidney's Revenue was $818,000 through Jun 30, 2026, up 55.2% year-over-year; for FY2025, it came in at $893,000.

  • In earlier years, Revenue was $76,000 in FY2024.
  • The Q2 2026 figure marks the lowest quarterly Revenue since Q4 2024.
  • Per Business Quant data, PROK's Revenue in the three quarters before Q2 2026 was $226,000 (Q1 2026), $225,000 (Q4 2025) and $217,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Prokidney 823.10 Mn 1.93 Bn - 150,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150,000.00
Mar 31, 2026 226,000.00
Dec 31, 2025 225,000.00
Sep 30, 2025 217,000.00
Jun 30, 2025 221,000.00
Mar 31, 2025 230,000.00
Dec 31, 2024 76,000.00
API Access

Prokidney Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=PROK&period=max&api_key=YOUR_API_KEY